The impact of human aged bone marrow niche on human hematopoietic stem cell function
This project aims to investigate how aging alters the human bone marrow niche and its impact on hematopoietic stem cell function to improve understanding and outcomes in elderly hematopoiesis.
Projectdetails
Introduction
In humans, aging of the hematopoietic system is associated with anemia, impaired immune responses, and increased frequency of myeloid malignancies. The hematopoietic system is maintained by hematopoietic stem cells (HSCs). HSCs reside in the bone marrow (BM) within specialized niches, where they self-renew and differentiate to produce all blood and immune cells.
Clinical Implications
In the clinical setting of BM transplantation, HSCs from older donors result in a reduced transplantation success, with a worse level of engraftment and higher overall mortality. This demonstrates that there is a reduction in the function of aged human HSCs (hHSCs). Causes of this impaired hHSC function with age still remain unclear.
Importance of Research
Therefore, it is of great importance to uncover and subsequently target factors that contribute to hHSC aging in order to attenuate impaired hematopoiesis in the elderly. Due to the lack of meaningful human BM (hBM) niche models in the aging field, the current understanding of how extrinsic changes (stemming from the aged hBM niche) contribute to the aging of hHSC is far less advanced compared to the knowledge of the contribution of cell-intrinsic changes.
Proposal Focus
Thus, this proposal focuses on providing a significant understanding of age-associated changes within the hBM niche and their contribution to the aging of hHSCs using an aging-centered hBM niche model. Transplantation of young BM hHSCs into this advanced niche model revealed that an aged hBM niche confers aging on young hHSCs.
Research Questions
To this end, the target of the proposal is to address the following questions:
- How does aging affect the cellular and molecular composition of the hBM niche?
- To which extent does an aged hBM niche affect aging of hHSCs?
- What are the underlying mechanisms that confer an age-like function on hHSCs?
Challenges Addressed
MANAGE HSC addresses both technological and conceptual challenges in studying the role of the hBM niche in regulating hHSC function in the context of normal hematopoiesis and aging.
Financiële details & Tijdlijn
Financiële details
Subsidiebedrag | € 1.500.000 |
Totale projectbegroting | € 1.500.000 |
Tijdlijn
Startdatum | 1-1-2025 |
Einddatum | 31-12-2029 |
Subsidiejaar | 2025 |
Partners & Locaties
Projectpartners
- UNIVERSITAET ULMpenvoerder
Land(en)
Vergelijkbare projecten binnen European Research Council
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
What does your blood remember? The memory of hematopoietic stem cells.This project aims to investigate how hematopoietic stem cells develop adaptive memory to environmental stress, enhancing blood cell responses and improving transplantation strategies. | ERC Starting... | € 2.500.000 | 2022 | Details |
Cell size as driver of stem cell aging and cancerThis project aims to investigate how cellular enlargement affects stem cell function and aging, potentially linking size to rejuvenation and cancer development, using mouse models for insights. | ERC Starting... | € 1.500.000 | 2024 | Details |
The Interplay of Aging, Immune Signaling and Stem Cell FunctionThis project aims to investigate how immune environment changes contribute to muscle stem cell dysfunction and regenerative decline in aging, with the goal of improving stem cell therapies. | ERC Consolid... | € 1.998.843 | 2024 | Details |
How is blood (re-)made? Regeneration of human hematopoietic stem cells after transplantationRESTART aims to enhance survival in pediatric HSCT by using multiomics to characterize human HSPC regeneration and identify predictors of adverse outcomes. | ERC Starting... | € 1.500.000 | 2024 | Details |
Unmasking the dynamic influence of the hematopoietic niche as an oncogenic path to myeloid neoplasms evolutionThis project aims to explore hematopoietic-niche interactions across myeloid neoplasm stages to develop innovative therapies that prevent acute myeloid leukemia and improve patient outcomes. | ERC Starting... | € 1.911.428 | 2024 | Details |
What does your blood remember? The memory of hematopoietic stem cells.
This project aims to investigate how hematopoietic stem cells develop adaptive memory to environmental stress, enhancing blood cell responses and improving transplantation strategies.
Cell size as driver of stem cell aging and cancer
This project aims to investigate how cellular enlargement affects stem cell function and aging, potentially linking size to rejuvenation and cancer development, using mouse models for insights.
The Interplay of Aging, Immune Signaling and Stem Cell Function
This project aims to investigate how immune environment changes contribute to muscle stem cell dysfunction and regenerative decline in aging, with the goal of improving stem cell therapies.
How is blood (re-)made? Regeneration of human hematopoietic stem cells after transplantation
RESTART aims to enhance survival in pediatric HSCT by using multiomics to characterize human HSPC regeneration and identify predictors of adverse outcomes.
Unmasking the dynamic influence of the hematopoietic niche as an oncogenic path to myeloid neoplasms evolution
This project aims to explore hematopoietic-niche interactions across myeloid neoplasm stages to develop innovative therapies that prevent acute myeloid leukemia and improve patient outcomes.
Vergelijkbare projecten uit andere regelingen
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Exploiting ex vivo expansion and deep multiomics profiling to bring novel, efficient and safer hematopoietic stem cell gene therapies to clinical applicationThis project aims to innovate hematopoietic stem cell identification and engineering through advanced culture techniques and multiomics profiling, enhancing gene therapy for blood disorders and cancer. | EIC Pathfinder | € 3.797.562 | 2022 | Details |
Exploiting ex vivo expansion and deep multiomics profiling to bring novel, efficient and safer hematopoietic stem cell gene therapies to clinical application
This project aims to innovate hematopoietic stem cell identification and engineering through advanced culture techniques and multiomics profiling, enhancing gene therapy for blood disorders and cancer.